Efficacy of Dapoxetine in the Treatment of Patients With Lifelong Premature Ejaculation as an Alternative to Sertraline Therapy

被引:6
|
作者
Liu, Guoxiong [1 ]
Yin, Yinghao [2 ]
Zhang, Lei [3 ]
He, Dalin [1 ]
Yang, Lin [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
[2] Cent South Univ, Dept Urol, Xiangya Hosp 3, Changsha, Hunan, Peoples R China
[3] Air Force Mil Med Univ, Dept Urol, Xijing Hosp, Xian, Shaanxi, Peoples R China
关键词
Dapoxetine; Sertraline; Premature ejaculation; Selective serotonin re-uptake inhibitors; INTERNATIONAL SOCIETY; DEFINITION; IMPACT; BLIND; MEN;
D O I
10.1016/j.esxm.2021.100473
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Before dapoxetine was approved for the treatment of lifelong premature ejaculation (LPE) in China, daily dosing with off-label sertraline was common. Aim: To investigate the efficacy of dapoxetine in the treatment of patients with LPE as an alternative to sertraline therapy. Methods: This prospective study included LPE patients who previously attempted treatment with sertraline and who agree to receive dapoxetine therapy in our hospital from January 2020 to March 2021. Patients who received any PE therapy in the two months prior to the dapoxetine therapy were excluded. All patients received dapoxetine 30 mg (taken 1-3 hours before sexual intercourse) for 12 weeks, and they were not taking sertraline during the trial. Main Outcome Measure: Data on their intravaginal ejaculatory latency time and premature ejaculation profile were recorded before and after the dapoxetine treatment. Clinical Global Impression of Change scores and data on Treatment-Emergent adverse events were collected after treatment. Results: A total of 144 patients with LPE completed this study; including 64 patients who reported that previous sertraline treatment was satisfactory (group A) and 80 patients for whom previous sertraline therapy was unsatisfactory in treating PE (group B). Both groups experienced significantly increased intravaginal ejaculatory latency time. Dapoxetine therapy was reported satisfactory by 67.5% of patients with LPE in whom sertraline therapy unsatisfactory according to their Clinical Global Impression of Change score, which was not different from those who reported this result in group A (62.5%). Similar outcomes were also reported for premature ejaculation profile and treatment-emergent adverse events. Conclusion: : Although both dapoxetine and sertraline are selective serotonin re-uptake inhibitors, dapoxetine therapy is satisfactory in 67.5% of patients with LPE in whom sertraline treatment unsatisfactory, and the effect of dapoxetine was independent of the effect of sertraline. Copyright (C) 2021 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Reasons and treatment strategy for discontinuation of dapoxetine treatment in premature ejaculation patients in China: A retrospective observational study
    Zhong, Chongfu
    Li, Chunlei
    Geng, Qiang
    Han, Qiang
    Gao, Qinghe
    Zhang, Jiwei
    Wang, Fu
    Guo, Jun
    ANDROLOGIA, 2022, 54 (07) : 1598 - 1604
  • [22] Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study
    Mathers, M. J.
    Klotz, T.
    Roth, S.
    Luemmen, G.
    Sommer, F.
    ANDROLOGIA, 2009, 41 (03) : 169 - 175
  • [23] Comparison Between On-Demand Dosing of Dapoxetine Alone and Dapoxetine Plus Mirodenafil in Patients with Lifelong Premature Ejaculation: Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
    Lee, Won Ki
    Lee, Seong Ho
    Cho, Sung Tae
    Lee, Yong Sung
    Oh, Cheol Young
    Yoo, Changhee
    Cho, Jin Seon
    Lee, Sang Kon
    Yang, Dae Yul
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 (11) : 2832 - 2841
  • [24] Altered reward processing in patients with lifelong premature ejaculation
    Li, Yansong
    Li, Xiaojun
    Wang, Zixiang
    Chen, Xi
    Sescousse, Guillaume
    Santtila, Pekka
    Dai, Yutian
    Zhang, Bing
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [25] Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review
    Russo, A.
    Capogrosso, P.
    Ventimiglia, E.
    La Croce, G.
    Boeri, L.
    Montorsi, F.
    Salonia, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (09) : 723 - 733
  • [26] Oral Agents for the Treatment of Premature Ejaculation: Review of Efficacy and Safety in the Context of the Recent International Society for Sexual Medicine Criteria for Lifelong Premature Ejaculation
    McMahon, Chris G.
    Porst, Hartmut
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (10) : 2707 - 2725
  • [27] Efficacy and Safety of Dapoxetine for the Treatment of Premature Ejaculation: Integrated Analysis of Results from Five Phase 3 Trials
    McMahon, Chris G.
    Althof, Stanley E.
    Kaufman, Joel M.
    Buvat, Jacques
    Levine, Stephen B.
    Aquilina, Joseph W.
    Tesfaye, Fisseha
    Rothman, Margaret
    Rivas, David A.
    Porst, Hartmut
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (02) : 524 - 539
  • [28] Premature ejaculation: the new definition and place of dapoxetine in current treatment
    Atan, Ali
    Aslan, Yilmaz
    TURKISH JOURNAL OF UROLOGY, 2010, 36 (02): : 149 - 154
  • [29] Comparative study of on-demand and daily use of sertraline in treatment of premature ejaculation: A randomized clinical trial
    Siroosbakht, Soheila
    Rezakhaniha, Sadra
    Rezakhaniha, Bijan
    ASIAN JOURNAL OF UROLOGY, 2021, 8 (02) : 209 - 214
  • [30] On-demand Take of Dapoxetine for the Treatment of Lifelong Premature Ejaculation: Prospective, Randomized, Placebo Controlled Study
    Li, Hong-yan
    Xing, Yuan-yuan
    Li, Hai
    PROCEEDINGS OF THE 2016 INTERNATIONAL CONFERENCE ON BIOMEDICAL AND BIOLOGICAL ENGINEERING, 2016, : 35 - 40